Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and JAMES DETAR

Colgate-Palmolive Stock Acts Like Young Growth Company

Staid home products giant Colgate-Palmolive, with roughly $20 billion annual sales, is acting more like a young growth stock. In mid-October its stock was at 67.62. Wednesday afternoon it was trading around 93, up 38% in seven months. It's no surprise the Colgate-Palmolive stock Relative Strength (RS) Rating climbed to 81 Wednesday, up from 78.

The upgraded 81 RS Rating indicates that Colgate-Palmolive stock outperformed 81% of all stocks in IBD's database over the past year. Further, market research shows that the top-performing stocks often have an RS Rating of over 80 as they launch their biggest runs.

Hone Your Stock-Picking Skills By Focusing On These Factors

Colgate-Palmolive Stock Lifted By Consumer Spending

New York-based Colgate Palmolive, which traces its roots back to 1806, sells a variety of products including Ajax cleanser and Irish Spring brand hand soap, along with baby care, pet food, deodorants, toothpaste and a host of other products. Its stock is rising as consumer spending remains robust despite still-elevated inflation.

Colgate-Palmolive stock trades well above its 21-day, 50-day and 200-day lines after the strong seven-month run.

Additionally, Colgate-Palmolive stock is considered extended and out of buy range after clearing an 85.01 buy point in a first-stage cup without handle. See if the stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.

Earnings growth moved up in the company's latest report to 18%, or 86 cents per share. It was the best showing in a year. The prior three quarters its EPS growth rose from 7% to 16% then 13%. Revenue grew 6% last quarter to $5.07 billion. Although not bad for a big-cap company, it was its weakest showing in a year. The prior three stanzas sales grew 8%, 10% and 7%.

Among Top 12% Of Stocks Overall

Among its other ratings, Colgate-Palmolive stock has an 88 Composite Rating, meaning it tops 88% of all stocks overall. It has an 84 Earnings Per Share Rating and a best-possible A SMR Rating (sales + profit margins + return on equity), mirroring its strong fundamentals. Finally, its A- Accumulation/Distribution Rating shows that institutional investors like mutual funds and university funds are strong buyers.

Colgate-Palmolive stock earns the No. 3 rank among its peers in the 40-stock Cosmetics/Personal Care industry group. FitLife Brands is the No. 1-ranked stock in the group.

IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matches up against other publicly traded companies.

Please follow James DeTar on X, formerly known as Twitter, @JimDeTar 

RELATED:

IBD Stock Rating Upgrades: Rising Relative Strength

Profit From Short-Term Trends With SwingTrader

How Relative Strength Line Can Help You Judge A Stock

Watch Our Market Experts Spot Top Stocks Each Morning On IBD Live

Ready To Grow Your Investing Skills? Join An IBD Meetup Group!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.